School of Medicine
Showing 241-260 of 354 Results
-
Melissa L Bondy
Stanford Medicine Discovery Professor, Professor of Epidemiology and Population Health and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsPrincipal Investigator, Discovery, Biology and Risk of Inherited Variants in Glioma, 1R01CA217105-01A1, NIH/NCI, 05/01/2018-06/30/2022, MPI (Contact PI)
Principal Investigator, Characterizing Germline and Somatic Alterations by Glioma Subtypes and Clinical Outcome, 1R01CA232754-01, 07/01/2019-06/30/2023, MPI (Contact PI)
Co-Leader (Project), SPORE in Brain Cancer, PI – Fred Lang (Sub with MD Anderson), 2 P50CA127001-11, 09/01/2019-08/31/2023
Co-Investigator, Stanford University Cancer Center, PI – Steve Artandi, P30 CA124435, NCI, 09/15/10-05/31/22
Co-Investigator, Ovarian Cancer Survival in African-American Women, PI, Joellen Schildkraut, R01 CA237318-01A1, NIH/NCI, 07/01/2020-06/31/2025 -
C. Andrew Bonham, MD, FACS
Associate Professor of Surgery (Abdominal Transplantation), Emeritus
Current Research and Scholarly InterestsTolerance induction in liver transplantation.
Hepatocyte transplantation. -
Bernardo Bonilauri
Instructor, Cardiovascular Institute
BioDr. Bonilauri is a highly driven and thoughtful scientist with a deep commitment to uncovering the molecular mechanisms that govern human biology and disease. After completing his postdoctoral training at the Stanford Cardiovascular Institute under the mentorship of Dr. Joseph C. Wu, he now serves as an Instructor, continuing his work on advanced in vitro disease modeling systems to explore fundamental questions in molecular and cellular biology.
His research integrates a broad array of disciplines, including multi-omics, tissue engineering, structural biology, and advanced imaging — providing a systems-level perspective on complex biological processes. This interdisciplinary expertise, combined with his analytical rigor, enables Dr. Bonilauri to investigate rare and understudied conditions such as Transthyretin Amyloidosis, where innovative research is urgently needed. He is also broadly interested in protein diversity, and actively investigates the existence and functional roles of microproteins encoded by small open reading frames (sORFs). His contributions have significant potential to inform the development of novel therapeutic strategies across a wide range of human diseases. -
Hector Fabio Bonilla
Clinical Associate Professor, Medicine - Infectious Diseases
BioAs a young physician at Louisiana State University, Dr. Bonilla focused on the Clinical Management of HIV/AIDS and HCV, two neglected and stigmatized diseases for which effective therapies were in their infancy. While learning the clinical aspects of the two diseases, Dr. Bonilla saw a need to create and organize a support community to promote understanding and management of the conditions. Subsequently, he went to Summa Health System in Akron, Ohio, and he continued his work where he specialized in HIV/HCV as well as in Infectious Diseases Clinical Practice. In addition to teaching medical residents and students, Dr. Bonilla participated in numerous clinical trials and developed clinical research projects. Furthermore, he led the Infection Renal Transplant Program, HIV and HCV clinics, and he participated in several cooperative studies with Case Western Reserve University. Dr. Bonilla’s interest in academia led him to the University Of Pittsburgh Medical Center where he was an Assistant Professor, Clinician, and Medical Educator in the Department of Medicine in the Division of Infectious Diseases. Due to his interest in cytokines and immunological responses, Dr. Bonilla became a researcher at ImmunoScience Inc., a biotechnology company in California that works to develop a therapeutic HIV vaccine. Dr. Bonilla’s experience of treating HIV/HCV combined with his interest in inflammatory response is the driving force behind his desire to understand ME/CFS. Dr. Bonilla is a strong patient advocate, and he believes in integrated care—care in which physicians communicate and coordinate efforts to deliver the best medical outcome for patients. His ME/CFS patients are his inspiration, and he is committed to continuing research to seek answers to their health challenges.
-
John Boothroyd
Burt and Marion Avery Professor of Immunology, Emeritus
Current Research and Scholarly InterestsWe are intereseted in the interaction between the protozoan parasite Toxoplasma gondii and its mammalian host. We use a combination of molecular and genetic tools to understand how this obligate intracellular parasite can invade almost any cell it encounters, how it co-opts a host cell once inside and how it evades the immune response to produce a life-long, persistent infection.
-
Donald E. Born
Clinical Professor, Pathology
BioDr. Born obtained his medical degree from the University of Virginia where he also completed a Ph.D. in Neuroscience. His next training occurred at the University of Washington as an Anatomic Pathology resident and Neuropathology fellow. He moved to Stanford in 2013 and as Clinical Professor of Pathology he sees a wide range of samples related to the field of neuropathology.
-
Mariya Borodyanskaya
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Mariya Borodyanskaya enjoys being part of the Stanford Team at Mills, an interdisciplinary team dedicated to supporting adolescents and their families in navigating the challenges of mental health crisis. She maintains a broad set of interests, including Post Traumatic Stress Disorder, Psychotic Disorders and Juvenile Justice system reform. She also enjoys supervising and teaching the Stanford Child & Adolescent Psychiatry fellows.
-
Amber Noelle Borucki
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Amber Borucki is an anesthesiologist and pain medicine specialist whose focus is chronic pain management in children and adolescents/young adults. She focuses on reducing or managing pain from chronic conditions or pain that occurs after surgery. Dr. Borucki completed her medical degree at Rush Medical College in Chicago, IL. She attended anesthesia residency at the University of Chicago. She completed a fellowship in pediatric anesthesiology at Boston Children's Hospital as well as a combined adult/pediatric pain medicine fellowship at Boston Children's Hospital, Brigham Women's Hospital, and Beth Israel Deaconess Medical Center. Dr. Borucki worked for one year in private practice in anesthesiology in Reno, Nevada. Dr. Borucki then worked for 5 years as a pediatric anesthesiologist and pain medicine specialist and was the Director of the Pediatric Anesthesia Service at UCSF Benioff Children's Hospital. Dr. Borucki transitioned to Stanford Medicine Children's Health in May 2023 and her clinical duties include working in the Emeryville satellite pediatric pain clinic, pediatric operating room, and pediatric pain inpatient service. Dr. Borucki is currently the Director for Pediatric Pain Education at Stanford.
Notable accomplishments include developing and co-chairing the UCSF Benioff Transbay Pediatric Pain Management Committee, development of the pediatric establishment of an adolescent/young adult transitional pain clinic, and serving on the Bridge to One Bay project to standardize pain care across all UCSF Benioff Children's Hospital locations. Dr. Borucki also was instrumental in helping UCSF Benioff Children's Hospital obtain ChildKind designation, a prestigious designation for a hospital indicating that it prioritizes pediatric pain care.
Dr. Borucki is a member of the medical advisory council for the Make a Wish Bay Area chapter. She is currently serving as the Secetary/Treasurer for the Society for Pediatric Pain Medicine (SPPM) and also served as the program director for the 12th annual SPPM meeting. Dr. Borucki has also served on several committees through the American Society of Anesthesiologists and California Society of Anesthesiologists. Dr. Borucki served as an editorial board member for Paediatric and Neonatal Pain. -
Rupan Bose, MD, MB
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioRupan Bose, MD, MB, is a Cardiologist and Clinical Assistant Professor in the Division of Cardiovascular Medicine at Stanford. He specializes in Preventive Cardiology, with a particular focus on high-risk populations.
Dr. Bose completed his medical degree from the Keck School of Medicine of USC. He then completed his internal medicine residency at USC, followed by his fellowship in cardiovascular medicine at Harbor-UCLA. He also has a particular interest in the intersection of medicine and technology, and he holds Masters in Biotechnology (MB) with an emphasis on Bioinformatics from the University of Pennsylvania. His research interests are investigating the underlying cardiovascular drivers of risk in high-risk ethnic groups, as well as investigating the role of emerging technologies and innovations in promoting cardiovascular disease monitoring and outcomes.
At Stanford, Dr. Bose serves in the Preventive Cardiology clinic and the Stanford South Asian Translational Heart Initiative (SSATHI) clinics, as well as in the inpatient cardiovascular services. -
Donna M. Bouley, DVM, PhD
Professor of Comparative Medicine at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsResearch interests: ocular pathology, host-pathogen interactions in infectious disease, infectious disease in frogs, phenotypic characterization of tg and ko mice, histopathology of minimally-invasive radiological ablation techniques (focused ultrasound, cryoablation).
-
Robert Downey Boutin
Clinical Professor, Radiology
BioDr. Boutin works clinically as a musculoskeletal radiologist interpreting a broad array of diagnostic imaging examinations, most frequently MRI, CT, sonography, and radiography.
The clinical focus for Dr. Boutin is MRI of joints, bones, and muscles, as well as adding value to routine radiology exams by translating advancements from fields of artificial intelligence and imaging informatics.
These advancements include enhancing routine imaging exams to help promote physical function, quality of life, and health span in our patients. Because the worldwide population of people > 60 years of age is projected to double by 2050, there is a crucial need for improvements in the accurate and efficient management of derangements associated with biological aging, including osteoporosis, sarcopenia, and visceral adiposity.
Dr. Boutin is a leader in the field of musculoskeletal imaging. He has served as the Chair of the Musculoskeletal Imaging Program Committee for the largest medical meeting in the world (RSNA) and is the President of the Society of Academic Bone Radiologists. Core professional values include an emphasis on outstanding quality, compassion, safety, and integrity.
Dr. Boutin was introduced to Orthopaedics at an early age by his father and older brother -- both orthopaedists. After earning undergraduate and graduate degrees at Stanford University, Dr. Boutin completed advanced fellowship training in Musculoskeletal Imaging at the University of California, San Diego, and worked on the faculty at Harvard Medical School.
Dr. Boutin is dedicated to excellence in musculoskeletal imaging. Dr. Boutin has written over 100 peer-reviewed articles and textbook chapters. He has also served as Guest Editor for 2 volumes of the 'Orthopaedic Clinics of North America', and volumes of ‘Seminars in Musculoskeletal Radiology’. Dr. Boutin also has served for many years as a Peer Reviewer for premier radiology journals.
Dr. Boutin is a popular invited lecturer for Continuing Medical Education Courses, such as those at the annual meetings of the 'Radiological Society of North America', the 'International Skeletal Society', the 'Arthroscopy Association of North America', the 'American Academy of Orthopaedic Surgeons', and the 'International Society for Magnetic Resonance in Medicine'. He is also a repeat lecturer at the prestigious Orthopaedic Imaging course in Davos, Switzerland. -
Raffick A.R. Bowen
Clinical Professor, Pathology
Current Research and Scholarly InterestsMy current research involves the investigation of immunoassay interferences from blood collection tube additives; particularly, silicone surfactants.